PRODUCTS
Multi Plex Matrix MPM-SL0905
Indication: HYPERLIPIDEMIA
MPM-SL0905 is a unique product with a “Dual Active Action Mechanism” allowing regularizing Cholesterol and Triglycerides.
MPM-SL0905 was tested for blood lipids management in a poloxamer-induced lipidemia model, high-fructose model, and on high-fat/high-cholesterol diet model.
MPM-SL0905 increases the ratio HDL/non-HDL comparable to lovastatin. An increase in this ratio is associated with a reduction of cardiovascular risks.
MPM-SL0905 decreases total plasma triglycerides and cholesterol comparable to a reduction observed with niacin.
MPM-SL0905 has a triple mechanism of action; reduced lipid absorption in the gut, improved lipid management in adipocytes and improved liver metabolism.
Technical Targeted Health Claim
Normalization of lipid profiles in individuals with high cholesterol levels
Ratio HDL/non-HDL of Golden Syrian hamsters treated or not with Lovastatin or MPM-SL095 for two weeks on a high fat high cholesterol (HFHC) diet.
The effect of niacin and MPM-SL095 on the percent reduction in total plasma triglycerides and cholesterol in P-407 treated Wistar rats.